Apotex’s planned IPO values generic drug maker at $5-billion
- Posted on June 1, 2026
- By The Globe and Mail
- 0 Views
- 1 min read
Apotex’s planned IPO values generic drug maker at $5-billion
Public offering would be the largest in Canada since 2021 and the largest ever in health sciences
